Navigation Links
PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
Date:10/6/2008

BOSTON, Oct. 6 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the William Blair Small-Cap Growth Stock Conference in New York, NY. James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 11:20 a.m. EDT on Tuesday, October 7, 2008.

A live webcast of this presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at http://www.PAREXEL.com. A replay of the presentation will be available until November 7, 2008.

About the Company

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has over 8,800 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.

PAREXEL is a registered trade
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
2. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
3. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
4. PAREXEL Closes the Acquisition of ClinPhone
5. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
6. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
8. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
9. PAREXEL Expands Global Clinical Logistics Capabilities
10. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
11. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 AACC ... to the 2015 AACC Annual Meeting & Clinical ... from July 26–30. The meeting showcased revolutionary advancements ... the ability of healthcare providers to diagnose patients ... effective medical treatment. As of ...
(Date:7/30/2015)... , ... July 30, 2015 , ... The 2015 Market ... study on the current state of the global Propanol market with a focus on ... BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG ...
(Date:7/30/2015)... CITY, Kan. , July 30, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the ... for companion animals, today announced that its strategic ... from a dose confirmation study of AT-016, an ... Aratana for the treatment of osteoarthritis pain in ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... PHILADELPHIA - For centuries, engineers have bent and torn ... scientists at the University of Pennsylvania School of Engineering ... at nanoscale sizes in the form of wires a ... has enable Penn engineers to construct a theoretical model ...
... Mass., March 3 ETEX Corporation, an advanced,biomaterials ... a supply,agreement with LifeNet Health, Inc., Under ... Bone Matrix (DBM) powder to be mixed with ... substitute material called,EquivaBone(TM). ETEX will manufacture EquivaBone(TM) in ...
... Human Genome,Sciences, Inc. (Nasdaq: HGSI ) announced ... Susquehanna Financial Group Second Annual SIGnificant,Investment Options in ... at http://www.hgsi.com ., (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ... Genome Sciences, clinical management team will,participate in a ...
Cached Biology Technology:Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover 2ETEX and LifeNet Health, Inc. Enter Agreement 2
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
(Date:7/20/2015)... 2015  Acuity Market Intelligence,s latest research "The ... Commerce and Privacy" forecasts that between 2014 and ... be downloaded to smart mobile devices by 2.2 ... is projected to generate more than $67.9 billion ... forecast period.    "Biometrics is at ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... (Feb. 29, 2012)Exposure to lead wreaks havoc in the ... potential for learning. But the precise mechanism by which ... remained unknown. New research led by Toms R. ... Health Sciences at Columbia University Mailman School of Public ...
... leading many growers to plant corn every year and ... yields, researchers report. In many instances, pesticides are applied ... violating a bedrock principle of integrated pest management. The ... and soybean fields in the agricultural Midwest, and signs ...
... Orleans, LA Research led by Nicolas Bazan, MD, PhD, ... at LSU Health Sciences Center New Orleans, has found that ... experimental stroke. Dr. Bazan was issued a patent on the ... the blood-brain barrier. The findings are published in the March ...
Cached Biology News:In what ways does lead damage the brain? 2Researcher tracks agricultural overuse of bug-killing technology 2Researcher tracks agricultural overuse of bug-killing technology 3Researcher tracks agricultural overuse of bug-killing technology 4LSUSHC research identifies new experimental drug for stroke 2
... The Vybrant Apoptosis Assay Kit ... of changes that occur in the permeability ... solutions of both YO-PRO-1 and propidium iodide ... through the plasma membranes of apoptotic cells ...
Request Info...
... Kit is an ultra-sensitive chemiluminescent Western ... It detects protein at attogram (10 ... -24 M) levels. This kit ... protein interaction system and detection system. ...
Request Info...
Biology Products: